EP 4240178 A1 20230913 - COMPOSITIONS FOR NASAL APPLICATION
Title (en)
COMPOSITIONS FOR NASAL APPLICATION
Title (de)
ZUSAMMENSETZUNGEN ZUR NASALEN APPLIKATION
Title (fr)
COMPOSITIONS POUR APPLICATION NASALE
Publication
Application
Priority
- EP 20205430 A 20201103
- EP 2021080455 W 20211103
Abstract (en)
[origin: CA3196962A1] The invention relates to pulverulent compositions for nasal application, containing taurine, caffeine, L-arginine and L-tryptophan. The invention further relates to containers and kits containing such compositions and to uses of the compositions.
IPC 8 full level
A23L 33/175 (2016.01); A61K 9/00 (2006.01); A61K 9/14 (2006.01); A61K 31/185 (2006.01); A61K 31/198 (2006.01); A61K 31/405 (2006.01); A61K 31/522 (2006.01); A61P 25/00 (2006.01)
CPC (source: EP US)
A23L 33/175 (2016.08 - EP); A61K 9/0043 (2013.01 - EP US); A61K 9/146 (2013.01 - EP); A61K 31/185 (2013.01 - EP); A61K 31/198 (2013.01 - EP US); A61K 31/405 (2013.01 - EP US); A61K 31/522 (2013.01 - EP US); A61P 25/00 (2018.01 - EP); A23V 2002/00 (2013.01 - EP)
C-Set (source: EP)
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
EP 3991573 A1 20220504; AU 2021374792 A1 20230608; CA 3196962 A1 20220512; EP 4240178 A1 20230913; US 2024342079 A1 20241017; WO 2022096481 A1 20220512
DOCDB simple family (application)
EP 20205430 A 20201103; AU 2021374792 A 20211103; CA 3196962 A 20211103; EP 2021080455 W 20211103; EP 21801136 A 20211103; US 202118251018 A 20211103